…rate or decreasing blood pressure, making it a consideration for patients with low blood pressure secondary to a low cardiac output. Its primary clinical utility…

…pharmacodynamic mechanisms. These drugs are broadly utilised to augment myocardial contractility, manipulate systemic and pulmonary vascular resistance, and restore adequate end organ perfusion. Dobutamine is…

…adventitial disease and trauma. Atherosclerotic PAD is a manifestation of systemic arterial disease rather than an isolated disorder of the lower limbs. Patients frequently have…

…patient with primary adrenal insufficiency (Addison's disease), secondary adrenal insufficiency or long term corticosteroid treatment cannot increase their own cortisol production. Situation Action : : Fever…

…Dietary composition may influence blood pressure, glucose–insulin homeostasis, lipids and apolipoproteins, endothelial function, systemic inflammation, liver fat synthesis, adiposity, thrombosis and coagulation, cardiac function…

…hemodynamic abnormality in HFpEF is impaired diastolic function. The left ventricle may have apparently preserved global systolic emptying while exhibiting impaired relaxation, increased passive stiffness…

…secondary contributor [8] . Pathophysiology and mechanisms The pathophysiological paradigm of HFpEF has shifted dramatically from the historical concept of isolated "diastolic dysfunction" to a systemic…

…secondary hypertension, treatment related contributors, and excess cardiovascular risk. The European definition requires failure to reduce office systolic and diastolic blood pressure to below 140…

…cause mortality. Absolute benefit is modest. Across the updated systematic review, absolute reductions in major ASCVD events ranged from 0.8% to 2.5%. In…

…Thresholds vary among guideline systems: Classification Fasting triglycerides Non fasting triglycerides Mild to moderate HTG 150–499 mg/dL (1.7–5.6 mmol/L…